Ironotectcan Hcl- Cancer/Oncology
Drug Name:
Ironotectcan Hcl- Cancer/Oncology
List Of Brands:
Indication Type Description:
Indication:
Cancer/oncology
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Irinotecan Hcl Anti cancer 23-05-1997 to
Trihydrate 22-05-1999
2.Irinotecan Hcl Trihydrate Injection 31-08-2010
20mg/ml (Pack size- 25ml)
For the treatment of metastatic colorectal cancer
Patent Expiry Date of drugs (Ref - IDMA Publication)
Chemical Category Manufacturer/ US Patent
Ingredient- Marketer Expiration Date
Ironotecan Cancer/ Aventis 20-08-2007
Hcl Oncology
Dosages/ Overdosage Etc:
Cancer/oncology